Merit Medical Systems, Inc. (MMSI)
NASDAQ: MMSI · Real-Time Price · USD
66.53
-0.36 (-0.54%)
At close: Jun 12, 2026, 4:00 PM EDT
66.28
-0.25 (-0.38%)
After-hours: Jun 12, 2026, 6:21 PM EDT
Merit Medical Systems Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Merit Medical Systems stock has a consensus rating of "Buy" and an average price target of $89.55. The average 1-year stock price forecast is 34.60% higher than the current stock price, while the lowest is $74 (+11.23%) and the highest is $110 (+65.34%).
Price Target: $89.55 (+34.60%)
Analyst Consensus: Buy
* Price targets were last updated on May 11, 2026.
Analyst Ratings
The average analyst rating for Merit Medical Systems stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 1 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Reiterates $96 | Buy | Reiterates | $96 | +44.30% | May 11, 2026 |
| Barrington | Barrington | Buy Maintains $107 | Buy | Maintains | $107 | +60.83% | May 1, 2026 |
| Robert W. Baird | Robert W. Baird | Buy Maintains $92 → $83 | Buy | Maintains | $92 → $83 | +24.76% | May 1, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $95 → $77 | Buy | Maintains | $95 → $77 | +15.74% | May 1, 2026 |
| Raymond James | Raymond James | Buy Maintains $101 → $83 | Buy | Maintains | $101 → $83 | +24.76% | May 1, 2026 |
Financial Forecast
Revenue This Year
1.62B
from 1.52B
Increased by 6.86%
Revenue Next Year
1.72B
from 1.62B
Increased by 6.06%
EPS This Year
4.07
from 3.83
Increased by 6.30%
EPS Next Year
4.40
from 4.07
Increased by 8.03%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.6B | ||
| Avg | 1.6B | ||
| Low | 1.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 7.4% | ||
| Avg | 6.9% | ||
| Low | 6.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.13 | ||
| Avg | 4.07 | ||
| Low | 4.03 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 7.8% | ||
| Avg | 6.3% | ||
| Low | 5.2% |